EI
CYTK icon

Ethic Inc’s Cytokinetics CYTK Stock Holding History

Ethic Inc’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Sell
18,965
-33
-0.2% -$2.37K 0.02% 569
2026
Q1 		$1.25M Buy
18,998
+2,158
+13% +$137K 0.02% 590
2025
Q4 		$1.07M Buy
16,840
+7,318
+77% +$455K 0.02% 624
2025
Q3 		$523K Buy
+9,522
New +$392K 0.01% 818

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ethic Inc's CYTK Position: Q2 2026 in Review

Ethic Inc reduced its Cytokinetics (CYTK) stake by 0.17% in Q2 2026, selling an estimated $2.37K and leaving 18,965 shares worth $1.62M. The position accounts for 0.02% of the portfolio, ranked #569.

Ethic Inc first reported a position in CYTK in Q3 2025 and has held it in 4 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Ethic Inc held 18,965 shares of Cytokinetics worth $1.62M as of Q2 2026.
  • Ethic Inc sold 33 Cytokinetics shares in Q2 2026, an estimated $2.37K.
  • Cytokinetics made up 0.02% of Ethic Inc's portfolio in Q2 2026, its #569 holding.
  • Ethic Inc first reported a position in Cytokinetics in Q3 2025 and has held it in 4 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.